2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of …

Authors/Task Force Members, SG Priori… - Ep …, 2015 - academic.oup.com
The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …

The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the …

P Lancellotti, PA Pellikka, W Budts… - European Heart …, 2016 - academic.oup.com
A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

Cardiovascular Research, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

[HTML][HTML] Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines

J Sultana, PM Cutroneo, S Crisafulli, G Puglisi… - Drug safety, 2020 - Springer
The global COVID-19 pandemic has led to a race to find medications that can improve the
prognosis of the disease. Azithromycin, in association with hydroxychloroquine or …

Mortality risk factors among hospitalized COVID-19 patients in a major referral center in Iran

NM Alamdari, S Afaghi, FS Rahimi, FE Tarki… - The Tohoku journal of …, 2020 - jstage.jst.go.jp
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has killed many people
worldwide since December 2019, and Iran has been among the most affected countries. In …

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

A Pani, M Lauriola, A Romandini… - International journal of …, 2020 - Elsevier
The emergence of the new COVID-19 virus is proving to be a challenge in seeking effective
therapies. Since the most severe clinical manifestation of COVID-19 appears to be a severe …

Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes

PJ Schwartz, RL Woosley - Journal of the American College of Cardiology, 2016 - jacc.org
Drug-induced long QT syndrome (diLQTS) and congenital LQTS (cLQTS) share many
features, and both syndromes can result in life-threatening torsades de pointes (TdP). Our …

Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease

JV Philley, RJ Wallace Jr, JL Benwill, V Taskar… - Chest, 2015 - Elsevier
BACKGROUND Bedaquiline is an oral antimycobacterial agent belonging to a new class of
drugs called diarylquinolines. It has low equivalent minimal inhibitory concentrations for …

An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections …

AC Bennett, CL Bennett, BJ Witherspoon… - Expert opinion on drug …, 2019 - Taylor & Francis
Introduction: Ciprofloxacin, levofloxacin, and moxifloxacin belong to the fluoroquinolone
class of antibiotics and are amongst the most commonly prescribed antibiotics. In 2018 and …

[HTML][HTML] Risk evaluation of azithromycin-induced QT prolongation in real-world practice

Y Choi, HS Lim, D Chung, J Choi, D Yoon - BioMed research …, 2018 - hindawi.com
Background. Azithromycin exposure has been reported to increase the risk of QT
prolongation and cardiovascular death. However, findings on the association between …